KUVATRIS THERAPEUTICS, INC. Operating Cash Flow
KUVATRIS THERAPEUTICS, INC. reported Operating Cash Flow of -$5.00 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2026-01-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-01-14
- KUVATRIS THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2024-09-30 was -$632.32K.
- KUVATRIS THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2024-06-30 was -$1.30M.
- KUVATRIS THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2024-03-31 was -$3.07M.
- KUVATRIS THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2023-12-31 was -$2.62M.
- KUVATRIS THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$10.77M.
- KUVATRIS THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$6.07M.
- KUVATRIS THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2021 was -$5.51M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2024-09-30 | -$632.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-01-14 | -$1.93M derived: sum of 2 quarters · filed 2026-01-14 | -$5.00M 10-Q · filed 2026-01-14 | -$7.62M derived: sum of 4 quarters · filed 2026-01-14 |
| 2024-06-30 | -$1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-09-20 | -$4.37M 10-Q · filed 2024-09-20 | -$6.99M derived: sum of 3 quarters · filed 2024-09-20 | -$9.32M derived: sum of 4 quarters · filed 2026-01-14 |
| 2024-03-31 | -$3.07M 10-Q · filed 2024-05-13 | -$5.69M derived: sum of 2 quarters · filed 2024-05-13 | -$8.02M derived: sum of 3 quarters · filed 2026-01-14 | -$10.85M derived: sum of 4 quarters · filed 2026-01-14 |
| 2023-12-31 | -$2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | -$4.95M derived: sum of 2 quarters · filed 2026-01-14 | -$7.79M derived: sum of 3 quarters · filed 2026-01-14 | -$10.77M 10-K · filed 2024-03-11 |
| 2023-09-30 | -$2.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-01-14 | -$5.17M derived: sum of 2 quarters · filed 2026-01-14 | -$8.15M 10-Q · filed 2026-01-14 | -$11.22M derived: sum of 4 quarters · filed 2026-01-14 |
| 2023-06-30 | -$2.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-09-20 | -$5.82M 10-Q · filed 2024-09-20 | -$8.89M derived: sum of 3 quarters · filed 2024-09-20 | -$10.46M derived: sum of 4 quarters · filed 2024-09-20 |
| 2023-03-31 | -$2.98M 10-Q · filed 2024-05-13 | -$6.05M derived: sum of 2 quarters · filed 2024-05-13 | -$7.62M derived: sum of 3 quarters · filed 2024-05-13 | -$8.66M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | -$4.64M derived: sum of 2 quarters · filed 2024-03-11 | -$5.68M derived: sum of 3 quarters · filed 2024-03-11 | -$6.07M 10-K · filed 2024-03-11 |
| 2022-09-30 | -$1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-16 | -$2.61M derived: sum of 2 quarters · filed 2023-11-16 | -$3.00M 10-Q · filed 2023-11-16 | -$4.25M derived: sum of 4 quarters · filed 2023-11-16 |
| 2022-06-30 | -$1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$1.43M 10-Q · filed 2023-08-09 | -$2.68M derived: sum of 3 quarters · filed 2023-08-09 | -$4.19M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$394.70K 10-Q · filed 2023-05-15 | -$1.64M derived: sum of 2 quarters · filed 2023-05-15 | -$3.15M derived: sum of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | -$1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$2.75M derived: sum of 2 quarters · filed 2023-03-30 | -$5.51M 10-K · filed 2023-03-30 | |
| 2021-09-30 | -$1.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$4.26M 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | -$2.76M 10-Q · filed 2022-09-30 |